Cheap high flyer healthcare stocks - high momentum and low valuation

[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration]
iQoncept/iStock via Getty Images

As earnings season ramps up and geopolitical tensions keep affecting the markets, below is a list of the top 10 healthcare sector stocks that are regarded as cheap high flyer stocks according to SA grading system. Each of these stocks is listed according to the highest momentum grade along with their valuation grade.

The list is topped by Climb Bio (CLYM [https://seekingalpha.com/symbol/CLYM]), with a momentum grade of A+ and valuation grade of B+. Fortrea Holdings Inc. (FTRE [https://seekingalpha.com/symbol/FTRE]) and GRAIL, Inc. (GRAL [https://seekingalpha.com/symbol/GRAL]) follow closely behind. Century Therapeutics, Inc. (IPSC [https://seekingalpha.com/symbol/IPSC]) and Ironwood Pharmaceuticals, Inc. (IRWD [https://seekingalpha.com/symbol/IRWD]) round out the rest of the top five.

Other high-ranking companies include PepGen Inc. (PEPG [https://seekingalpha.com/symbol/PEPG]) and ALX Oncology Holdings Inc. (ALXO [https://seekingalpha.com/symbol/ALXO]). The list also features Coherus Oncology, Inc. (CHRS [https://seekingalpha.com/symbol/CHRS]), Contineum Therapeutics, Inc. (CTNM [https://seekingalpha.com/symbol/CTNM]), and Ekso Bionics Holdings, Inc. (EKSO [https://seekingalpha.com/symbol/EKSO]), representing a range of market capitalizations within the healthcare sector.

Momentum grades are given on a scale from A+ to F, with A+ representing the highest flyer stocks with the best momentum. Valuation grades are also given on a scale from A+ to F, with A+ being the most undervalued (cheapest) and F being the most overvalued.

Here is the list:

*
Climb Bio (CLYM [https://seekingalpha.com/symbol/CLYM]), Momentum: A+, Valuation: B+

*
Fortrea Holdings (FTRE [https://seekingalpha.com/symbol/FTRE]), Momentum: A+, Valuation: B-

*
GRAIL (GRAL [https://seekingalpha.com/symbol/GRAL]), Momentum: A+, Valuation: B-

*
Century Therapeutics (IPSC [https://seekingalpha.com/symbol/IPSC]), Momentum: A+, Valuation: A-

*
Ironwood Pharmaceuticals (IRWD [https://seekingalpha.com/symbol/IRWD]), Momentum: A+, Valuation: B+

*
PepGen (PEPG [https://seekingalpha.com/symbol/PEPG]), Momentum: A+, Valuation: B

*
ALX Oncology Holdings Inc. (ALXO [https://seekingalpha.com/symbol/ALXO]), Momentum: A, Valuation: B

*
Coherus Oncology (CHRS [https://seekingalpha.com/symbol/CHRS]), Momentum: A, Valuation: A-

*
Contineum Therapeutics (CTNM [https://seekingalpha.com/symbol/CTNM]), Momentum: A, Valuation: B-

*
Ekso Bionics Holdings (EKSO [https://seekingalpha.com/symbol/EKSO]), Momentum: A, Valuation: B-

Health Care ETFs: (XLV [https://seekingalpha.com/symbol/XLV]), (VHT [https://seekingalpha.com/symbol/VHT]), (IHI [https://seekingalpha.com/symbol/IHI]), (IXJ [https://seekingalpha.com/symbol/IXJ]), (IYH [https://seekingalpha.com/symbol/IYH]), (FHLC [https://seekingalpha.com/symbol/FHLC]), and (FXH [https://seekingalpha.com/symbol/FXH])

MORE ON HEALTHCARE STOCKS

* CMS Rates Proposal Shatters Health Insurance Stocks: What Investors Must Know (& Do) [https://seekingalpha.com/article/4863386-cms-rates-proposal-shatters-health-insurance-stocks-what-investors-must-know-and-do]
* Insurers Brace For Extended 'Managed Retreat' Following 2027 MA Proposal [https://seekingalpha.com/article/4863331-insurers-brace-for-extended-managed-retreat-following-2027-ma-proposal]
* XLV Vs. BME: Total Return Or Income, Which Healthcare Strategy Wins? [https://seekingalpha.com/article/4859754-xlv-vs-bme-total-return-or-income-which-healthcare-strategy-wins]
* FDA opens fast-track program to speed U.S. drug plant construction [https://seekingalpha.com/news/4545112-fda-opens-fast-track-program-to-speed-u-s-drug-plant-construction]
* Notable healthcare headlines for the week: UnitedHealth, Novo Nordisk, and Thermo Fisher in focus [https://seekingalpha.com/news/4545015-notable-healthcare-headlines-for-the-week-unitedhealth-novo-nordisk-thermo-fisher-in-focus]